HLVX Chart
See on advanced chart >
About
HilleVax, Inc. was incorporated in the state of Delaware in March 25, 2020. The company is a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines. The company's initial program, HIL-214, is a virus-like particle...
Read More
- HighlightA biopharmaceutical company that developing novel vaccines for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection
- ExchangeNASDAQ
- Listing Date04/29/2022
- Established Date03/25/2020
- Full-time Employees90
- Address321 Harrison Avenue Boston Massachusetts 02118
- Tel1-617-2135054
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals